IN2012DN01849A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01849A
IN2012DN01849A IN1849DEN2012A IN2012DN01849A IN 2012DN01849 A IN2012DN01849 A IN 2012DN01849A IN 1849DEN2012 A IN1849DEN2012 A IN 1849DEN2012A IN 2012DN01849 A IN2012DN01849 A IN 2012DN01849A
Authority
IN
India
Prior art keywords
vwf
provides methods
present
von willebrand
willebrand factor
Prior art date
Application number
Other languages
English (en)
Inventor
Mitterer Artur
Hasslacher Meinhard
Mayer Christa
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN01849(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of IN2012DN01849A publication Critical patent/IN2012DN01849A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN1849DEN2012 2009-08-20 2010-08-20 IN2012DN01849A (Direct)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23557009P 2009-08-20 2009-08-20
PCT/US2010/046180 WO2011022657A1 (en) 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses

Publications (1)

Publication Number Publication Date
IN2012DN01849A true IN2012DN01849A (Direct) 2015-08-21

Family

ID=43063204

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1849DEN2012 IN2012DN01849A (Direct) 2009-08-20 2010-08-20

Country Status (18)

Country Link
US (1) US9315560B2 (Direct)
EP (1) EP2467399B2 (Direct)
JP (1) JP5838159B2 (Direct)
KR (1) KR101894600B1 (Direct)
CN (2) CN106008697B (Direct)
AU (1) AU2010284116B9 (Direct)
BR (1) BR112012003802B1 (Direct)
CA (1) CA2771232A1 (Direct)
DK (1) DK2467399T3 (Direct)
ES (1) ES2562256T5 (Direct)
HU (1) HUE026907T2 (Direct)
IN (1) IN2012DN01849A (Direct)
MX (1) MX2012002129A (Direct)
NZ (1) NZ598249A (Direct)
PL (1) PL2467399T3 (Direct)
PT (1) PT2467399E (Direct)
SG (2) SG178478A1 (Direct)
WO (1) WO2011022657A1 (Direct)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
NZ592704A (en) 2008-10-21 2013-02-22 Baxter Int Lyophilized recombinant von willebrand factor (rVWF) formulation comprising buffering agents, amino acids, stabilising agents and surfactants
MY173835A (en) * 2012-06-21 2020-02-24 Baxter Int Virus filtration of cell culture media
EP2958995A4 (en) 2013-02-22 2016-11-23 Agency Science Tech & Res CHROMATOGRAPHIC CLEANING OF VIRUS PREPARATIONS WITH NEGATIVELY LOADED PARTICLES
RU2714154C2 (ru) * 2014-06-06 2020-02-12 Октафарма Аг Препарат, содержащий фактор viii и пептиды фактора фон виллебранда
AU2015274238B2 (en) 2014-06-13 2020-11-05 Csl Limited Improved production of recombinant von Willebrand factor in a bioreactor
US20200199176A1 (en) 2017-08-23 2020-06-25 Csl Behring Gmbh Method for virus filtration of von willebrand factor
CN112533940A (zh) 2018-03-21 2021-03-19 百深公司 通过色谱方法分离vwf和vwf前肽
EP4490042A1 (en) 2022-03-08 2025-01-15 Equashield Medical Ltd. Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
AU591671B2 (en) 1985-04-11 1989-12-14 Children's Medical Center Corporation Von willebrand factor
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
US6531577B1 (en) 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
KR101036414B1 (ko) * 1998-05-06 2011-05-23 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
PT1835938E (pt) 2004-12-27 2013-11-06 Baxter Int Conjugados de polímero-factor de von willebrand

Also Published As

Publication number Publication date
EP2467399A1 (en) 2012-06-27
JP5838159B2 (ja) 2015-12-24
PL2467399T3 (pl) 2016-05-31
AU2010284116A1 (en) 2012-03-08
KR101894600B1 (ko) 2018-09-03
DK2467399T3 (en) 2017-01-23
MX2012002129A (es) 2012-06-08
EP2467399B2 (en) 2023-02-01
WO2011022657A1 (en) 2011-02-24
CN106008697B (zh) 2020-08-04
KR20120065342A (ko) 2012-06-20
BR112012003802B1 (pt) 2022-10-25
ES2562256T3 (es) 2016-03-03
AU2010284116B9 (en) 2015-03-26
AU2010284116B2 (en) 2015-02-12
CN106008697A (zh) 2016-10-12
NZ598249A (en) 2014-04-30
SG178478A1 (en) 2012-04-27
US20110092681A1 (en) 2011-04-21
SG10201408106WA (en) 2015-01-29
ES2562256T5 (es) 2023-07-20
PT2467399E (pt) 2016-03-18
CN102482341A (zh) 2012-05-30
EP2467399B1 (en) 2015-11-11
CA2771232A1 (en) 2011-02-24
BR112012003802A2 (pt) 2016-11-22
HUE026907T2 (en) 2016-07-28
JP2013502434A (ja) 2013-01-24
US9315560B2 (en) 2016-04-19

Similar Documents

Publication Publication Date Title
IN2012DN01849A (Direct)
IN2014DN08481A (Direct)
GB0917002D0 (en) Improved shigella blebs
MA35660B1 (fr) Inhibiteurs de la protéine pak pour le traitement du syndrome de l'x fragile
EA201390145A1 (ru) Конъюгаты, частицы, композиции и связанные с ними способы
EA201190224A1 (ru) Ингибиторы гепатита c, содержащие конденсированные кольца
SG10201804385YA (en) Stimulus responsive polymers for the purification of biomolecules
MY161252A (en) Viral inactivation using improved solvent-detergent method
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
EA201391175A1 (ru) Гетеродимерные иммуноглобулины
UA105785C2 (uk) Спосіб очищення ліпопептидів
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
EA202193044A2 (ru) Способы лечения таупатии
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EP2588083A4 (en) BIOMATRIXGERÜSTE
UA110470C2 (ru) Антидот антикоагулянта
EP2352515A4 (en) METHOD FOR TREATING HEMOPHILIA
EA201590887A1 (ru) Композиция
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
UA107476C2 (uk) Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів
UY34329A (es) Compuestos de triazolopiridina
MY164954A (en) Method for purifying organic diphosphite compounds
DE102010002121B8 (de) Lichtbogen-Schweißverfahren und Schweißstromquelle zur Durchführung des Verfahrens
WO2014093627A3 (en) Compositions and methods for inhibiting viral entry
CO6821958A2 (es) Tetrahidroquinolinas condensadas con cicloalquilo como moduladores de receptores de crth2